Key result
Dexmedetomidine premedication dose-dependently decreased the total amount of thiopental needed for minor gynecologic surgery from 400 mg (0.167 µg/kg dose) to 180 mg (1.0 µg/kg dose) (P=0.028).
Why the study?
Does dexmedetomidine premedication reduce anesthetic requirements in healthy women undergoing minor gynecologic surgery?
Population
20 healthy (ASA physical status I) women scheduled for uterine dilatation and curettage
Design
Single-blind
Authors
Loading...
May reduce thiopental needs in select cases; hypothesis-generating and requires randomized confirmation before practice change.
RCT (n=20)
Single-blind
Does dexmedetomidine premedication reduce anesthetic requirements in healthy women undergoing minor gynecologic surgery?
Absolute Event Rate: 180% vs 400%
p-value: p=0.028
Dexmedetomidine premedication dose-dependently reduces thiopental requirements and sympathetic tone during minor gynecologic surgery.
Aantaa et al. (1990) conducted an RCT in Minor gynecologic surgery (uterine dilatation and curettage) (n=20). Dexmedetomidine vs. Lower doses of dexmedetomidine was evaluated on Total amount of thiopental needed to perform uterine dilatation and curettage (p=0.028). Dexmedetomidine premedication dose-dependently decreased the total amount of thiopental needed for minor gynecologic surgery from 400 mg (0.167 µg/kg dose) to 180 mg (1.0 µg/kg dose) (P=0.028).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: